دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان
- قیمت ویژه : 2,400,000تومان
سفارش
دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 1,500,000 تومان
- قیمت ویژه : 750,000تومان
سفارش
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency
doi : 10.1016/j.euo.2025.04.026
خرید پکیج و مشاهده آنلاین مقاله
Re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. 10.1016/j.eururo.2025.09.4144
doi : 10.1016/j.euo.2025.10.015
خرید پکیج و مشاهده آنلاین مقاله
Reply to Constance Huck, Paul Sargos, and Alberto Bossi’s Letter to the Editor re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. 10.1016/j.eururo.2025.09.4144
doi : 10.1016/j.euo.2025.11.012
خرید پکیج و مشاهده آنلاین مقاله
Re: M. Roupret, A. Bertaut, G. Pignot, et al. ALBAN (GETUG-AFU 37): A Phase 3, Randomized, Open-label, International Trial of Intravenous Atezolizumab and Intravesical Bacillus Calmette–Guérin (BCG) Versus BCG Alone in BCG-naive High-risk, Non-muscle-invasive bladder cancer (NMIBC). Ann Oncol. In press. 10.1016/j.annonc.2025.09.017
doi : 10.1016/j.euo.2025.12.003
خرید پکیج و مشاهده آنلاین مقاله